Lorcaserin Extended-Release Tablets and Omacetaxine Subcutaneous
Determining the interaction of Lorcaserin Extended-Release Tablets and Omacetaxine Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: lorcaserin
Brand name: Belviq, Belviq XR
Synonyms: Lorcaserin
Generic Name: omacetaxine
Brand name: Synribo
Synonyms: Omacetaxine, Omacetaxine Mepesuccinate
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Lorcaserin Extended-Release Tablets-Omacor
- Lorcaserin Extended-Release Tablets-Omadacycline
- Lorcaserin Extended-Release Tablets-Omadacycline Injection
- Lorcaserin Extended-Release Tablets-Omadacycline Intravenous
- Lorcaserin Extended-Release Tablets-Omadacycline oral/injection
- Lorcaserin Extended-Release Tablets-Omadacycline Tablets
- Omacetaxine Subcutaneous-Lorcaserin Hydrochloride
- Omacetaxine Subcutaneous-Lorcaserin Tablets
- Omacetaxine Subcutaneous-Lorcet
- Omacetaxine Subcutaneous-Lorcet Plus
- Omacetaxine Subcutaneous-Lorcet Tablets
- Omacetaxine Subcutaneous-Lorlatinib